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THE ANTIMICROBIAL EFFECT OF STERIPLEX
TM
 HC IN COMPARISON WITH SODIUM 
HYPOCHLORITE ON ENTEROCOCCUS FAECALIS 
 
By Jonathan P. Coudron, DDS 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
in Dentistry at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2012. 
 
Director: Karan J. Replogle, DDS, MS 
Department Chair, Department of Endodontics 
 
 
 
The study objective was to compare the antimicrobial activity of STERIPLEX™ HC with 
5.25% sodium hypochlorite (NaOCl) at different dilutions (50%, 25%, 10%, 1%, 0.1%) and 
different time intervals (1, 3, 5 minutes) on Enterococcus faecalis.  All data was analyzed using 
an ANOVA. 
The 50%, 25%, and 10% dilutions of both disinfectants reduced the colony forming unit 
(CFU) count to below the limit of detection (50 CFU/ml) after one minute.  The 1% dilutions at 
each of the time intervals show NaOCl was significantly more effective than STERIPLEX™ HC 
(all Ps < .0001) in reducing the CFU/ml count.  The 0.1% dilutions of NaOCl and 
STERIPLEX™ HC at 1 minute, were not different (P = 0.7808), while at 3 minutes and 5 
minutes NaOCl was significantly more effective (P = 0.0098 and P < .0001, respectively).   
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Introduction 
 
  
 
The etiology of endodontic infections has been well documented to be of 
microbiotic origin.  In 1965, Kakehashi et al demonstrated that pulp exposures in 
conventional lab rats resulted in apical periodontitis and eventually became abscesses, 
while germ free rats with pulp exposures retained normal apical tissue and healed 
coronally with dentinal bridging (1).  In 1976, Sundqvist sampled necrotic traumatized 
human teeth with intact crowns and discovered that bacteria were only present in teeth 
with radiographic evidence of apical periodontitis (2).  Möller and others studied the 
result of microorganisms in exposed monkey teeth.  When teeth were devitalized 
aseptically and immediately sealed, they retained healthy periodontium.  Teeth that were 
devitalized and left open to oral microorganisms showed inflammatory reactions 
clinically and radiographically.  All the infected teeth histologically examined showed 
inflammatory reactions in the periapical region (3).  More recently, Lin et al obtained 
similar results in a dog study.  Devitalized dog teeth were either sealed immediately or 
left exposed to the oral microorganisms for seven days and then sealed.  One year later, 
histological examination indicated that uninfected pulp tissue did not cause persistent 
periapical inflammation while the infected pulp tissue showed varying degrees of 
periapical inflammation (4).   It has been shown that failure of endodontic treatment is 
due to the presence of microorganisms either having remained in or re-colonized the 
obturated root canal (5).  Altogether, there is extensive data to conclude that oral 
microorganisms play a major role in endodontic infections.     
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One of the primary purposes of non-surgical root canal therapy, therefore, is to 
eliminate the microorganisms and the associated infected and necrotic pulpal remnants in 
order to prevent or cure apical periodontitis.  Studies have demonstrated that mechanical 
debridement of the canal alone is insufficient to disinfect the root canal.  Bystrom and 
Sundqvist evaluated in vivo the quantity of bacteria before and after root canal treatment 
with saline as the irrigant and stainless steel instruments for mechanical debridement.  
They found an initial bacteria load of 10
4
-10
6
 that was reduced by only 10
2
-10
3
 fewer 
bacteria cells after treatment.  Some of the teeth even demonstrated an increase in 
bacterial numbers between appointments (6).  More recently, Dalton et al performed a 
similar study using saline as the irrigant and compared bacteria reduction of stainless 
steel hand instrumentation to nickel titanium rotary instrumentation.  They found no 
detectable difference in the number of colony forming units between the two groups and 
that neither technique could sufficiently disinfect the canal (7). These in vivo bacterial 
studies are in agreement with a microcomputed tomography (CT) scanning study 
performed in vitro that revealed regardless of the instrumentation technique, 35% or more 
of the canal surface area remained untouched (8).  Thus, mechanical debridement alone is 
insufficient to render the root canal free of bacteria.  
Irrigants are required to adequately eliminate the microbiota and its associated 
biofilm from the root canal.  In addition, an ideal irrigant should be able to dissolve 
necrotic pulp tissue within the canal and simultaneously be nonirritating to the periapical 
tissues. The ideal irrigant would also have a prolonged antimicrobial effect long after the 
canal is dried, be able to inactivate endotoxin and microbial byproducts that initiate the 
host inflammatory response, be able to completely remove the smear layer or prevent the 
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formation thereof, be active in the presence of blood, serum, and protein derivatives of 
tissue, have low surface tension, not stain tooth structure, be able to disinfect the 
underlying dentin and its tubules, have no adverse effects on the physical properties of 
exposed dentin, have no adverse effects on the sealing ability of filling material, have 
convenient application, and be relatively inexpensive (9, 10).  Many irrigating solutions 
have been studied but no current disinfectant possesses all the desired characteristics.  
Some are frequently used in alternating sequence during treatment for the combined 
properties.     
The irrigant sodium hypochlorite possesses many of the desired properties of a 
disinfecting solution.  Its antimicrobial effect has been well studied.  Bystrom and 
Sundqvist showed that 0.5% NaOCl was better than saline in reducing the bacterial load 
in a clinical study (11).  Radcliffe et al examined the effectiveness of different 
concentrations of NaOCl at different time intervals against microbiota associated with 
refractory endodontic infections in planktonic solution.  They found 0.5% NaOCl was 
able to eradicate Actinomyces israelii and Canidia albicans after 10 seconds.  In contrast, 
0.5% NaOCl required 30 minutes to eradicate Enterococcus faecalis but only 2 minutes 
when using 5.25% NaOCl (12).  Barnard et al also found that a low concentration of 1% 
NaOCl was sufficient to eliminate Actinomyces israelii in suspension in only one minute 
(13).  Waltimo et al also found that a low concentration of 0.5% NaOCl eradicated all the 
Candida albicans yeast cells within 30 seconds in a filter plate suspension test (14).  In 
contrast to the Radcliff study, Siqueira et al found no difference in the antimicrobial 
effectiveness of 1%, 2.5% and 5.25% NaOCl after instrumentation in extracted teeth 
contaminated with E. faecalis.  All concentrations significantly reduced the bacterial load 
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(15).  The concentration of NaOCl that should be employed to retain the best 
antimicrobial properties is debatable, however it has been clearly shown that NaOCl is an 
effective antimicrobial agent against planktonic microbiota in endondontic treatment.     
Bacteria growing in sessile surroundings like biofilms are more difficult to 
eradicate than planktonic microorganisms and represent a more realistic environment of 
what is found inside the root canal system of necrotic teeth (16).  NaOCl has been shown 
to be an effective antimicrobial agent against biofilms.  Dunavant et al grew E. faecalis 
biofilms using the flow cell system and then immersed the biofilms in various irrigants 
for 1 and 5 minutes.  They found that only NaOCl, at either 1% or 6%, was able to 
effectively eliminate the E. faecalis grown in the biofilms (17).  Clegg et al grew 
polymicrobial biofilms on apical root sections and then immersed the sections in different 
irrigant solutions for 15 minutes (6%, 3%, 1% NaOCl, 1% NaOCl and MTAD, 2% 
chlorhexidine).  They concluded that only the 6% NaOCl was able to both completely 
eliminate the bacteria and physically remove the biofilm (18).  Therefore, low 
concentrations of NaOCl are effective at killing microorganisms within a biofilm and 
higher concentrations are additionally effective in removing the biofilm from the root 
canal system. 
Sodium hypochlorite is effective at dissolving tissue.  Hand et al demonstrated 
that 5.25% NaOCl can dissolve necrotic rat tissue most effectively when compared to 
lower concentrations (19).  Rosenfeld et al demonstrated that 5.25% NaOCl is capable of 
dissolving vital pulp tissue, verified histologically after extraction for orthodontic 
purposes (20).  
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Gram-negative bacteria found in the infected root canal contain an endotoxin, 
lipopolysaccaride (LPS), on their outer membrane that elicits a host inflammatory 
response even after the bacterial cell itself has been killed (21). Buck et al studied in vitro 
the effects of endodontic irrigants and calcium hydroxide, an intracanal medicament, on 
LPS using mass spectrometry/gas chromatography.  They found water, 
ethylenediaminetetraacetic acid (EDTA), ethanol, 0.12% chlorhexidine, chlorhexidine 
plus NaOCl, and NaOCl alone showed little breakdown of LPS after 30 minutes.  Only 
calcium hydroxide after 1, 2, or 5 days detoxified the LPS (22).  Martinho and Gomes 
quantified bacteria and LPS levels in vivo before and after chemomechanical 
instrumentation with 2.5% NaOCl in teeth with pulp necrosis and apical periodontitis.   
They found a moderate bacterial load reduction of 99.78% but a less effective endotoxin 
reduction of 59.99%.  They also found a significant correlation between more symptoms 
with a higher endotoxin level (23).   NaOCl therefore is not effective in eliminating LPS.  
A disadvantage of NaOCl is the risk of possible cytotoxicity and corresponding 
inflammation if expressed in sufficient amounts past the minor apical foramen.  Simbula 
et al found that even at a low concentration of 0.025%, NaOCl killed 60% of cultured 
fibroblasts after 2 hours of exposure (24).  However, in vitro and animal studies do not 
always correspond to in vivo human studies.  On the premise that cytotoxicity would 
elicit pain, Harrison et al studied the difference in inter-appointment discomfort when 
using 5.25% NaOCl or saline for irrigation on vital and nonvital teeth with and without 
apical radiolucencies.  They found no significant relationship between the types of 
irrigant used and the incidence or degree of inter-appointment pain among the groups 
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(25).  In summation, albeit rare, there are reports in the literature concerning hypochlorite 
accidents related to its cytotoxicity, which is a concern when using NaOCl (26-27).   
During instrumentation of the root canal, a smear layer is produced that consists 
of organic and inorganic substances including microorganisms, necrotic material, and 
remnants of odontoblastic processes (28).   The smear layer blocks the dentinal tubules 
thereby preventing disinfection by the irrigant.  Peters et al examined teeth with 
periapical lesions and found bacteria present in the dentinal tubules close to the 
cementum (29).  Baumgartner and Mader found that while NaOCl was able to remove the 
pulp tissue and predentin in instrumented canals it did not remove the smear layer.  
Ethylenediaminetetraacetic acid (EDTA) was capable of removing the inorganic smear 
layer but not the pulp tissue or predentin.  When both were used in alternating 
combination, the smear layer, pulp tissue, and predentin were all removed, exposing the 
orifices of the dentinal tubules and providing disinfection therein (30).  In addition, 
Bystrom and Sundqvist showed, in an in vivo study, that the use of 5% NaOCl and EDTA 
was more effective in reducing the bacterial load than the use of NaOCl alone (31).  
Thus, if NaOCl is to be used as the main irrigant, another solution must be used as an 
adjunct in removal of the smear layer.  
 Precautions should also be taken when using NaOCl so as not to overly expose 
the dentin and thereby weaken it.  Grigoratos et al evaluated the effect of 3% and 5% 
NaOCl on the flexural strength and modulus of elasticity of standardized dentine bars.  
After a 2 hour exposure time, a significant decrease in both the flexural strength and 
modulus of elasticity was found but no difference between the two concentrations was 
noted (32).  While important to understand, a two hour exposure time does not 
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necessarily correlate with the typical clinical exposure time of NaOCl to the dentinal 
tubules during endodontic therapy.  However, Marending et al later performed a similar 
study comparing the effects of 2.5% NaOCl and 17% EDTA individually and when used 
alternatively on the elastic modulus and flexure strength of dentin bars when exposed for 
only 24 minutes and 3 minutes, respectively.  No statistical difference in elastic modulus 
values after exposure to either solution when compared to pure saline was found.  In 
contrast, flexure strength was significantly reduced when exposed to NaOCl.  Thus, 
NaOCl can cause undesirable reduction in flexure strength, thereby weakening the tooth 
after a minimum dentin exposure of only 24 minutes (33).             
The actions of NaOCl are a result of the halogen chloride’s reactivity.  In water, 
NaOCl ionizes to sodium (Na
+
) and hypochlorite (OCl
-
).  The hypochlorite ion then 
establishes equilibrium with hypochlorous acid (HOCl).  At a high pH of 9 and above, 
the hypochlorite ion predominates, whereas at neutral or acidic pH, chlorine exists 
predominantly as hypochlorous acid (34). Hypochlorous acid is a more effective 
antimicrobial than the hypochlorite ion (34).  Studies show that the hypochlorous acid 
disrupts several vital functions of the microbial cell resulting in death.  Barrette et al 
showed that in the presence of hypochlorous acid bacterial cells permanently lost the 
ability to produce ATP, resulting in cell death (35).  McKenna and Davies showed a 
correlation between reduction in both DNA synthesis and protein synthesis as the 
exposure time and concentration of hypochlorous acid increased (36).  Arnhold et al 
discovered that hypochlorous acid reacts with double bonds of unsaturated phospholipids 
and fatty acids (37).  More recently, Prutz confirmed interactions between hypochlorous 
acid and the amine, thio, and disulfide groups of amino acids, nucleotides, and 
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corresponding DNA.  He suggested the mechanism of action is chlorination of the 
microbial molecules rather than the conventional theory of oxidation (38).  Regardless of 
the exact mechanism, NaOCl causes alterations within the cells it enters that ultimately 
result in death.   
Because NaOCl is not a perfect irrigant, or rather it does not posses all the ideal 
properties and does have associated risks, other disinfectants have been investigated for 
use as endondontic irrigants.  For example, Chorhexidine digluconate (CHX) is a strong 
base that has been shown to be a powerful antibacterial agent.  In fact, in an in vitro study 
on infected, freshly extracted human teeth, Jeansonne and White found no significant 
difference in antimicrobial effectiveness between 2% CHX and 5.25% NaOCl when 
either was used throughout instrumentation and as the final rinse (39).  In regards to 
cytotoxicity, 2% CHX has been used in periodontal therapy without any irritating effect 
on the gingival tissue (40).  However, CHX is not capable of dissolving tissue.  Naenni et 
al incubated pig palates in a 10% solution of CHX and found that it had no substantial 
tissue dissolving capacity (41).  Furthermore, CHX cannot eliminate LPS any better than 
NaOCl (22).  One in vivo study showed that after chemomechanical preparation using 
CHX gel in infected necrotic teeth, 99.97% of the bacteria were eradicated but only a 
44% reduction in endotoxin concentration occurred (42).  Also, CHX is not capable of 
disinfecting and removing the biofilm complex found in necrotic teeth (17, 18).  
Therefore, it is not recommended as the main irrigant.   
One beneficial property of CHX is its substantivity. An in vitro study showed that 
CHX can adhere to hydroxyapatite and tooth surfaces (43).  Furthermore, as the 
environmental concentration of CHX decreases, attached CHX is released, potentially 
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providing long-term antimicrobial activity (43).  White et al confirmed its continued 
antimicrobial property at 72 hours when using the 2% CHX solution (44).   
Due to its substantivity, CHX has been recommended as the final irrigant prior to 
obturation.  In fact, Zamany et al found significantly less bacteria following treatment 
when 2% CHX was used as an additional rinse after 1% NaOCl (45).  More recently, 
Baca et al found that after rinsing dentin blocks with a 2% CHX solution, 100% biofilm 
inhibition occurred after a 24 hour exposure to E. faecalis, while a rinse with 2.5% 
NaOCl only inhibited 18% of the biofilm formation (46).  Thus CHX is advantageous to 
use as the final but not main irrigant.  
Chelating solutions such as EDTA and citric acid have been recommended for use 
as adjuncts to NaOCl to help remove the smear layer.  Zaccaro et al found both 10% 
citric acid and 17% EDTA to effectively decalcify instrumented teeth in vitro at 3, 10, 
and 15 minutes with no significant difference between the two acids (47).  Either solution 
by itself cannot be used as the main irrigant, however, since each lack the ability to 
effectively kill microorganisms (48).   
Currently the recommended sequence of irrigants is NaOCl throughout 
instrumentation for its dissolving and antimicrobial properties followed by EDTA for 
removal of the smear layer and a final rinse with CHX for additional broad spectrum 
antibacterial effectiveness and substantivity (10).   
New irrigating agents brought to market recently attempt to improve upon 
existing properties of the already mentioned irrigants and/or combine the properties into a 
“two in one solution” to reduce disinfection time during therapy.  SmearClear (Sybron 
Endo, Orange, CA) is one such product.  It combines EDTA with a detergent in hopes to 
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lower its surface tension and thereby improve its penetration into the dentinal tubules.  In 
vitro studies thus far, however, have shown no improvements in smear layer removal 
between SmearClear, EDTA or citric acid (49, 50).  Similarly, the product Chlor-XTRA 
(Vista Dental Products, Racine, WI) combines hypochlorite with a detergent.  Studies 
thus far show an increase in speed of tissue dissolving effectiveness of NaOCl with the 
added detergent (51).   Surfactants have also been added to CHX with significant 
benefits.  Shen et al found CHX-Plus (CHX with surfactants, Vista Dental Products, 
Racine, WI) to have higher levels of bactericidal activity on exposed biofilm than 2% 
CHX (52).   
MTAD (BioPure MTAD; Dentsply Tulsa Dental Specialties, Tulsa, OK) was 
developed for use after irrigating with NaOCl to improve upon current chelating agents 
by removing the smear layer and disinfecting the root canal system with one agent.  It 
consists of doxycycline, citric acid, and a detergent, Tween 80 (53). In a published in 
vitro study by the developers, 17% EDTA and MTAD both effectively removed the 
smear layer in instrumented canals that had been previously irrigated with 5.25% NaOCl.  
However, EDTA caused significantly more erosion in the coronal portion of the canal 
than MTAD.  Interestingly, it has been recommended not to rinse with EDTA for over 
one minute (54), yet in this study the rinse was for 5 minutes.  Regarding antimicrobial 
effectiveness, the developers showed that 1.3% NaOCl with MTAD as a final rinse was 
significantly more effective against E. faecalis grown in extracted teeth than 5.25% 
NaOCl with EDTA (55).   
In contrast, others have performed similar studies but either found no difference 
in the antimicrobial efficacy between the two protocols (56) or significantly more 
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bacteria remaining in the canal with the 1.3%NaOCl/MTAD group (57).  Also, in direct 
comparison to NaOCl, while NaOCl is capable of disinfecting and removing the biofilm 
complex found in necrotic teeth, MTAD is not (17, 18).  Finally, in a randomized, 
controlled, double-blinded clinical trial, researchers found that a final rinse with MTAD 
did not reduce bacterial counts beyond levels achieved after canal preparation with 1.3% 
NaOCl (58).  Therefore, the benefits of MTAD remain questionable.   
Tetraclean (Ogna Laboratori Farmaceutici, Milano, Italy) was recently developed 
with similar ingredients and purpose as MTAD.  The purpose was for smear layer 
removal with the added benefit of antimicrobial activity.  Tetraclean differs from MTAD 
in type of detergent included (polypropylene glycol verses Tween for MTAD) and 
amount of doxycycline (50mg/5ml vs. 150mg/5ml of MTAD) (59).  In regards to 
antimicrobial ability, Giardino et al compared Tetraclean to MTAD and 5.25% NaOCl 
for antibacterial effectiveness against E. faecalis biofilms.  Although NaOCl proved 
significantly more effective than the two former solutions, Tetraclean was significantly 
better than MTAD in reducing the bacterial load (60).  Another benefit of Tetraclean, 
according to Giardino is its lower surface tension when compared to 5.25% NaOCl, 17% 
EDTA, Smearclear, or MTAD, which may allow deeper penetration into dentinal tubules 
(59).  Additional studies confirming the previous results by authors other than the 
primary developer would be prudent.  A concern of tetracycline related to tooth staining 
and antibiotic resistance has been raised due to the presence of doxycycline in both 
MTAD and Tetraclean (61).   
Another recently introduced product is QMix
TM
 (Tulsa Dental Specialties, 
Johnson City, TN).  It is advertised as an antimicrobial and smear layer removal agent to 
 - 12 - 
 
be used after NaOCl (a 2 in 1 solution).  QMix
TM
 is a combination of bisbiguanide- an 
antimicrobial agent, polyaminocarboxylic acid- a chelating agent, saline, and a 
surfactant-for lower surface tension.  A recent study on extracted teeth using an open 
canal system showed QMix
TM
 to be equally effective as 17% EDTA in removing the 
smear layer (62).  Additional studies are required for further investigation concerning 
antimicrobial effectiveness. 
Currently there is no irrigant that possesses all the properties of an ideal 
endodontic disinfectant.  There is not an irrigant that completely disinfects or sterilizes 
the entire tooth with the current techniques used in root canal treatment (63).  The search 
for a new and improved product continues.  
Recently a novel disinfectant named STERIPLEX
TM
 (sBioMed, Orem, UT) was 
introduced to the market.  STERIPLEX
TM
 is a peroxyacetic acid (PAA)-based chemical 
disinfectant that is available in two concentrations: 0.25% PAA (STERIPLEX
TM
 HC) and 
1.3% PAA (STERIPLEX
TM
 Ultra).  STERIPLEX
TM
 Ultra is available only to the military 
specifically for the decontamination of anthrax spores while STERIPLEX
TM
 HC (Health 
Care) is available to the public for disinfection of surfaces.  According to the material 
safety data sheet, STERIPLEX
TM
 HC is a two part system that when combined, creates 
an effective sterilant/sporicide, tuberculocide, antiviral, bactericide and deodorizer.  The 
combined ingredients include peroxyacetic acid, hydrogen peroxide, acetic acid, glycerol, 
ethanol, sorbitol, silver, and water.  The patented formula has been approved by the 
Environmental Protection Agency, is non-corrosive to the skin, does not exhibit oral or 
inhalational toxicities and stimulates only mild irritation when sprayed in the eyes. The 
solution is also non-oxidizing to materials and therefore is non-corrosive (64).  An 
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independent laboratory study, as discussed in the white paper, claims STERIPLEX
TM
 
Ultra to exhibit exceptionally fast sporicidal kinetics, being able to kill B. subtilis spores 
in suspension about 1,000 times faster than CIDEX
TM
, a commonly used sporicide that 
contains glutaraldehyde (65).  Disinfectants capable of destroying spores in the past such 
as aldehydes (glutaraldehyde), peroxygens (peracetic acid and hydrogen peroxide), 
ethylene oxide, and of particular interest to our specialty chlorine-releasing agents 
(hypochlorite) can be toxic to humans, corrosive to various materials, and may require 
long contact times (66, 67).  There are currently no published studies by an unpaid third 
party to validate the present statements concerning the effectiveness of STERIPLEX
TM
. 
Individually, the ingredients in STERIPLEX
TM
 have been studied.  PAA, the 
active ingredient in STERIPLEX
TM
, is a strong oxidizer on most macromolecules and has 
been shown to be bactericidal, sporicidal, and fungicidal at concentrations < 0.3% (34).  
Unlike NaOCl (68), PAA remains active in the presence of organic material (69).  Naenni 
et al found that 10% PAA is incapable of dissolving necrotic tissue (70).  De-Deus et al 
found that a 0.5% PAA exposure for 60 seconds is as effective as 17% EDTA for 
removal of the smear layer (71).  Dornelles-Morgental et al found 1% PAA to be a less 
effective antibacterial agent than 2.5% NaOCl, 2% CHX and other irrigants against E. 
faecalis (72).   STERIPLEX
TM 
HC could prove to be an effective disinfectant in root 
canal therapy.  The first step would be to verify its antimicrobial effectiveness against the 
gold standard, NaOCl.    
The purpose of this study was to compare the antimicrobial activity of 
STERIPLEX
TM
 HC with 5.25% NaOCl on Enterococcus faecalis.  Because of its 
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prevalence in persistent endodontic infections, E. faecalis was chosen as the test 
organism (73, 74, 75).   
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Materials and Methods 
 
 
 
E. faecalis was cultured in Brain Heart Infusion (BHI) broth overnight at 37°C.  
The next day an optical density (OD) spectrophotometer reading at 660nm wavelength 
(Unicam Helios Delta, England) was taken to verify growth.  After which, 980 µl of the 
cell culture suspension was combined with 420 µl glycerol.  Aliquots were then created 
by pipetting 50 µl of the E.  faecalis/glycerol suspension into 1.5 ml microcentrifuge 
tubes.  The aliquots were stored in a freezer at -70°C.  The E. faecalis V583 was a 
clinical isolate obtained from Thomas et al (76).  
A 5.25% NaOCl (A-1 Commercial; James Austin Company, Mars, PA) and 
unmixed STERIPLEX
TM
 HC (sBioMed, Orem, UT) solution was acquired and stored at 
room temperature.  The STERIPLEX
TM
 HC solution was mixed as directed prior to each 
experiment.  A 5% sodium thiosulfate solution was created to neutralize the NaOCl 
solution.  The STERIPLEX
TM
 HC neutralizer consisted of 12.7 ml Tween80, 6.0 g 
Tamol, 1.7 g Lecithin, 1.0 g Peptone, 1.0 Cysteine, 25 ml 2M Tris pH 7.0, and 55 ml 
distilled water.  The protocol was obtained from Richard Robinson at Brigham Young 
University.  The STERIPLEX
TM
 HC neutralizer was prepared immediately prior to each 
experiment due to precipitation of ingredients over time.  Preliminary studies showed that 
each neutralizer was effective at both neutralizing its respective solution and not altering 
the CFU/ml of E. faecalis.    
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The day preceding each experiment, an aliquot was removed from the freezer and 
5 µl of the E. faecalis/glycerol suspension was added to 10 ml of BHI broth.  The culture 
was incubated at 37 °C overnight.  An OD 660 nm reading was taken before each 
experiment to verify growth.   
Prior to the experiment, phosphate buffered saline (PBS) was added to the 
disinfectants to create the desired final concentration (50%, 25%, 10%, 1%, 0.1%) after 
combination with the E. faecalis. For example, PBS was not added to any disinfectant for 
the 50% suspension since it was to contain 50% E. faecalis suspension and 50% 
disinfectant.  However for the 25% suspension, 500 µl of PBS was added to 500 µl of the 
disinfectant prior to contact with E. faecalis.  Likewise, 800 µl of PBS was added to 200 
µl of the disinfectant for the 10% suspension, 980 µl of PBS was added to 20 µl of the 
disinfectant for the 1% suspension, and 998 µl of PBS was added to 2 µl of disinfectant 
for the 0.1% concentration.   
Under a hood, 1 ml of the E. faecalis suspension was dispensed into each of two 
tubes (15 ml polypropylene tube).  At time zero, 1 ml of each disinfectant (for the 50% 
suspension) or disinfectant/PBS solution (for all other suspensions) was placed in one of 
the tubes.  Both tubes were vortexed for 5 seconds.  At 1, 3 and 5 minutes, 10 µl of the E. 
faecalis/disinfectant suspension was removed from each tube and placed into a tube (1.5 
ml polypropylene micro-centrifuge tube) containing 990 µl of the corresponding 
neutralizer and vortexed for 3 seconds.  The experiment was repeated three times for each 
suspension.   
The neutralized suspension was serially diluted in PBS.  The number of viable 
organisms in selected dilution tubes was assayed by drop plating using the Miles and 
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Misra technique (77).  In brief, each agar plate was divided into six sections.  For each 
dilution, 20 µl was transferred to each of 3 spots in a given section of a plate.  Plating was 
performed in duplicate, such that there were six spots for CFU counting per dilution.  The 
plates were incubated at 37 °C overnight.  The following morning, the CFU’s were 
counted using Alpha Innotech Imager 2200 (Cell Bioscience, Santa Clara, CA) and 
CFU/ml determined using the appropriate dilution. 
The original concentration of E. faecalis was determined by using the same 
protocol as previously described except with PBS in place of the disinfectant.  The 
STERIPLEX
TM
 HC neutralizer was chosen as the neutralizer solution to which would be 
added the E. faecalis/PBS solution since preliminary experiments showed neither 
neutralizer to have any effect on the number of CFU/ml of E. faecalis.     
A negative control was performed by plating all solutions and agar by itself to 
verify the agar and reactants used were sterile, or in other words not contaminated.  
Statistical analysis was completed to compare the disinfectants at each time 
interval for each suspension with the original E. faecalis concentration and with each 
other.  The log-transformed values were analyzed using ANOVA and then the estimates 
back-transformed into geometric means for interpretation. 
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Results 
 
The OD readings of the E. faecalis cultures grown overnight for the 50%, 25% 
and 10% dilution tests were 1.22, 1.267 and 1.233 respectively.  Figures 1, 2 and 3 show 
the mean CFU/ml of planktonic E. faecalis after exposure to a 50%, 25% and 10% 
dilution of 5.25% NaOCl or STERIPLEX
TM
 HC at 1, 3 and 5 minutes.  The mean 
CFU/ml for the positive control group was 1.625 × 10
7
 for the 50% and 10% suspension 
and 1.761 ×10
7
 for the 25% suspension.  The 50%, 25% and 10% dilution of 5.25% 
NaOCl and STERIPLEX
TM
 HC reduced the CFU/ml to below the limit of detection (50 
CFU/ml) at all three time intervals.  Statistical analysis was not performed on any of 
these suspensions since a complete kill was achieved by both disinfectants at all time 
intervals.  The negative controls showed no growth for all the experiments. 
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Figure 1: 50% Disinfectant Suspension  
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Figure 2: 25% Disinfectant Suspension  
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Figure 3: 10% Disinfectant Suspension  
 
The OD reading of the E. faecalis culture grown overnight for the 1% dilution test 
was 1.21.  Figure 4 shows the mean CFU/ml of planktonic E. faecalis after exposure to a 
1% dilution of 5.25% NaOCl or STERIPLEX
TM
 HC at 1, 3 and 5 minutes.  The numeric 
values are shown in Table 1.  The mean CFU/ml for the positive control group was 1.649 
× 10
7
.  The corresponding 95% Confidence Interval (CI) indicates a 95% confidence that 
the CFU’s counted will range between 1.338 × 107 and 2.033 × 107 CFU/ml.  The 1% 
dilution of 5.25% NaOCl reduced the CFU/ml to 8.043 × 10
5
 at 1 minute with a 95% CI 
between 7.128 × 10
5
 and 9.077 × 10
5
.  In contrast, the 1% dilution of STERIPLEX
TM
 HC 
only reduced the CFU/ml to 1.605 × 10
7
 at 1 minute with a 95% CI between 1.422 × 10
7
 
and 1.811 × 10
7
.  The 1% dilution of 5.25% NaOCl at 3 minutes reduced the CFU/ml to 
5.993 × 10
4
 with a 95% CI between 5.310 × 10
4
 and 6.763 × 10
4
.  In contrast, the 1% 
dilution of STERIPLEX
TM
 HC at 3 minutes only reduced the CFU/ml to 1.598 × 10
7
 with 
a 95% CI between 1.416 × 10
7
 and 1.803 × 10
7
.  The 1% dilution of 5.25% NaOCl at 5 
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minutes reduced the CFU/ml to 6.582 × 10
3
 with a 95% CI between 5.833 × 10
3
 and 
7.428 × 10
3
.  In contrast, the 1% dilution of STERIPLEX
TM
 HC at 5 minutes only 
reduced the CFU/ml to 1.646 × 10
7
 with a 95% CI between 1.459 × 10
7
 and 1.858 × 10
7
.     
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Figure 4: 1% Disinfectant Suspension  
 
The ANOVA results comparing the log-transformed CFU/ml for the 1% dilutions 
indicated that the seven groups shown in Table 1 and Figure 4 were different (P < .0001).  
There was a significant difference between the control and the NaOCl groups (P < 
.0001). The 1, 3, and 5 minute NaOCl groups were each significantly below the control 
mean (Ps all < 0.0001). The STERIPLEX
TM
 HC means were not significantly different 
than the control mean (P = 0.98).  The 1% suspensions at each of the time intervals show 
NaOCl was significantly more effective than STERIPLEX
TM
 HC (Ps all < .0001) in 
reducing the CFU/ml count. 
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Table 1: 1% Results—Comparison of CFU/ml across the groups 
 CFU/ml Geometric Mean 
Agent Estimate 95% CI 
Control 1.649E+07 1.338E+07 2.033E+07 
NaOCl 1min 8.043E+05 7.128E+05 9.077E+05 
NaOCl 3min 5.993E+04 5.310E+04 6.763E+04 
NaOCl 5min 6.582E+03 5.833E+03 7.428E+03 
Stpx 1min 1.605E+07 1.422E+07 1.811E+07 
Stpx 3min 1.598E+07 1.416E+07 1.803E+07 
Stpx 5min 1.646E+07 1.459E+07 1.858E+07 
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Figure 5: 0.1% Disinfectant Suspension  
 
The OD reading of the E. faecalis solution grown overnight for the 0.1% 
suspension test was 1.208.  Figure 5 shows the mean CFU/ml of planktonic E. faecalis 
after exposure to a 0.1% suspension of 5.25% NaOCl or STERIPLEX
TM
 HC at 1, 3 and 5 
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minutes.  The numeric values are shown in Table 2.  The mean CFU/ml for the positive 
control group was 1.624 × 10
7
 with a 95% CI range between 1.517 × 10
7
 and 1.738 × 10
7
 
CFU/ml.  The 0.1% suspension of 5.25% NaOCl reduced the CFU/ml to 1.552 × 10
7
 at 1 
minute with a 95% CI between 1.492 × 10
7
 and 1.614 × 10
7
.  In contrast, the 0.1% 
suspension of STERIPLEX
TM
 HC reduced the CFU/ml to 1.610 × 10
7
 at 1 minute with a 
95% CI between 1.548 × 10
7
 and 1.675 × 10
7
.  The 0.1% suspension of 5.25% NaOCl at 
3 minutes reduced the CFU/ml to 1.443 × 10
7
 with a 95% CI between 1.388 × 10
7
 and 
1.501 × 10
7
.  In contrast, the 0.1% STERIPLEX
TM
 HC at 3 minutes reduced the CFU/ml 
to 1.582 × 10
7
 with a 95% CI between 1.521 × 10
7
 and 1.646 × 10
7
.  The 0.1% 
suspension of 5.25% NaOCl at 5 minutes reduced the CFU/ml to 1.287 × 10
7
 with a 95% 
CI between 1.237 × 10
7
 and 1.338 × 10
7
.  In contrast, the 0.1% STERIPLEX
TM
 HC at 5 
minutes reduced the CFU/ml to 1.568 × 10
7
 with a 95% CI between 1.508 × 10
7
 and 
1.631 × 10
7
. 
 
Table 2: 0.1% Results—Comparison of CFU/ml across the groups 
 CFU/ml Geometric Mean 
Agent Estimate 95% CI 
Control 1.624E+07 1.517E+07 1.738E+07 
NaOCl 1min 1.552E+07 1.492E+07 1.614E+07 
NaOCl 3min 1.443E+07 1.388E+07 1.501E+07 
NaOCl 5min 1.287E+07 1.237E+07 1.338E+07 
Stpx 1min 1.610E+07 1.548E+07 1.675E+07 
Stpx 3min 1.582E+07 1.521E+07 1.646E+07 
Stpx 5min 1.568E+07 1.508E+07 1.631E+07 
 
 
The ANOVA results comparing the log-transformed CFU/ml for the 0.1% 
suspensions indicated that the seven groups shown in Table 2 and Figure 5 were different 
(P < .0001).  However, the NaOCl 1 minute group was not different than the control (P = 
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0.25).  The 3 and 5 minute NaOCl groups were significantly below the control mean (Ps 
all < 0.0037).  The STERIPLEX
TM
 HC means were not significantly different than the 
control mean (P = 0.72).  The 0.1% suspensions of NaOCl and STERIPLEX™ HC at 1 
minute, were not different (P = 0.7808), while at 3 minutes and 5 minutes the NaOCl was 
significantly more effective (P = 0.0098 and P < .0001, respectively). 
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Discussion 
 
The main etiology of endodontic infections has been well documented to be of 
microbiotic origin (1, 2, 3, 4, 5).  One of the primary purposes of non-surgical root canal 
therapy, therefore, is to eliminate the microorganisms and the associated infected and 
necrotic pulpal remnants in order to prevent or cure apical periodontitis.  Because 
mechanical debridement of the canal alone is insufficient to disinfect the root canal (6, 7, 
8), irrigants are required.  NaOCl is the most commonly used irrigant because it possesses 
many of the desired characteristics of an ideal irrigant.  Studies have shown that NaOCl is 
effective as an antimicrobial agent (11, 12, 17), at removing biofilm (18), and dissolving 
tissue (19, 20).  However, NaOCl is not effective in eliminating LPS (22, 23), is 
associated with the risk of cytotoxicity (24, 26, 27), does not remove or prevent 
formation of a smear layer (30), and may cause reduction in flexural strength when 
exposed to dentin (33).  Because of these limitations, other irrigants have been 
investigated for the purpose of replacing NaOCl or to be used in combination with 
NaOCl to increase effectiveness.  Currently NaOCl is still most commonly used as the 
primary irrigant because of its unsurpassed antibacterial and dissolving capabilities.  Still, 
even when various irrigating solutions are combined for optimal therapeutic goals, 
complete sterilization of the root canal remains difficult to achieve (63).  Thus the search 
for an improved ideal irrigating solution in root canal therapy continues.  
The present study investigated a novel disinfectant, STERIPLEX
TM
 HC, as a 
potential endodontic irrigant.  STERIPLEX
TM
 Ultra was recently developed for use in 
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elimination of bacterial spores and is available only to the military.  A less concentrated 
solution, STERIPLEX
TM
 HC has been formulated for use in healthcare.  Both products 
have shown rapid sporicidal activity (65).  Currently, no studies have been completed 
which test the antimicrobial effectiveness of STERIPLEX
TM
 HC against bacteria found in 
endodontic infections.  The investigator felt it wise to begin tests by first evaluating the 
antibacterial effectiveness of STERIPLEX
TM
 HC against the gold standard, NaOCl.  In 
this study the antibacterial effectiveness of 5.25% NaOCl was compared with 
STERIPLEX
TM
 HC using E. faecalis as the test organism.  E. faecalis was chosen as the 
test organism because it is the dominant species recovered in failed endodontic cases (73-
75) and has been used in previous experiments (78-85).   
The comparison was accomplished by performing a standard kill time suspension 
test and using a spot plating technique to count remaining colony forming units.  Five 
different percentages of the total suspension (50%, 25%, 10%, 1%, 0.1%) of the two 
disinfectants were exposed to a planktonic solution of E. faecalis for 1, 3 and 5 minutes 
and were then assayed for remaining vital bacteria by counting CFU’s on agar plates.  A 
similar protocol has been implemented in previous studies to test antimicrobial 
effectiveness and was also implemented here (12, 79-81).  For the purpose of comparison 
with previous NaOCl studies, the 50%, 25%, 10%, 1%, and 0.1% suspensions are 
approximately 5.25%, 2.6%, 1.05%, 0.1% and 0.01% NaOCl respectively.  
The results from the present study show that 5.25%, 2.6%, and 1.05% NaOCl 
reduced the CFU/ml to below the limit of detection (50 CFU/ml) after one minute.  While 
the 0.1% NaOCl significantly reduced the quantity of bacteria after 1, 3 and 5 minutes (P 
all < 0.0001) it did not result in a complete kill.  The 0.01% NaOCl was able to 
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significantly reduce the quantity of bacteria after 3 and 5 minutes (P all < 0.0037) but 
also did not result in a complete kill.  Previous studies on NaOCl with similar protocols 
show comparable results (12, 79-81) while those with a protocol more closely reflecting 
an in vivo study (e.g. infected dentinal tubules in extracted teeth) had more contrasting 
data (15, 78, 82-85).   
Vianna and Gomes tested the efficacy of NaOCl against E. faecalis using a 
similar protocol as the present study (79).  They found 5.25% NaOCl completely 
inhibited any growth after just 30 seconds while 2.5% and 1% NaOCl required 3 minutes 
and 5 minutes respectively.  Similarly, the present study found that 5.25% could 
completely inhibit growth or eradicate the E faecalis suspension in 60 seconds.  In 
contrast, the present study found that both 2.6% and 1.3% NaOCl also achieved a 
complete kill in just 60 seconds. 
Radcliffe et al also used a similar protocol to determine the effectiveness of 
different concentrations of NaOCl at different time intervals against microbiota 
associated with refractory endodontic infections in planktonic solution (12).  Similar to 
the present study, they found that 5.25% and 2.5% NaOCl reduced the CFU of E. faecalis 
to below the limit of detection (limit not given) in 2 and 5 minutes, respectively.  In 
contrast, they found 1.0% NaOCl required 10 minutes to reduce the CFU to below the 
limit of detection while in the present study the 1.05% NaOCl reduced the CFU to below 
the limit of detection (50 CFU/ml) in 1 minute.   
Abdullah et al studied the effect 3% NaOCl had on a suspension of E. faecalis at 
different time intervals and found, similar to the present study, that one minute of 
exposure resulted in 100% bacterial reduction (80).  In addition, Gomes et al performed a 
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suspension test with E faecalis and found 5.25% NaOCl resulted in 100% inhibition of 
growth after 30 seconds but that 2.5%, 1% and 0.5% required 10, 20, and 30 minutes 
respectively for the same (81).  
Slight differences in the results from the present study and those in the past using 
similar protocols could be from small alterations in methods.  For example, in the current 
study the mean bacteria concentration found in the suspension was 1.653 ×10
7
 CFU/ml 
while those of other studies ranged from 1.5 × 10
8
 CFU/ml to 9.6 ×10
9 
CFU/ml.  The 
initial bacterial concentration in suspension could impact the effectiveness of the 
disinfectant.  Also, the strain of E. faecalis used could have had a significant impact on 
the result of other studies.  Furthermore, a difference in ratios of NaOCl to E. faecalis 
could account for slight differences in the studies.   
Because suspension tests do not reflect the in vivo conditions in which bacteria 
may grow as biofilms and into the dentinal tubules, the results from such studies 
generally show NaOCl as more effective than those studies performed in the in vitro 
setting.  For example, Retamozo et al recently found that 5.25% NaOCl required 40 
minutes to completely eradicate the E. faecalis in contaminated dentin cylinders.  As 
exposure time and concentration was decreased the presence of remaining E. faecalis 
increased, thus, showing a high concentration of 5.25% NaOCl at a long exposure 
interval of 40 minutes is required for elimination of E. faecalis in contaminated dentin 
(78).  In contrast to the Retamozo study, Siqueira et al found no difference in the 
antimicrobial effectiveness of 1%, 2.5% and 5.25% NaOCl after instrumentation in 
extracted teeth contaminated with E. faecalis.  All concentrations significantly reduced 
the bacterial load (15).  It is important to note, however, that Siqueira et al used paper 
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points in the main canal to sample for the presence of bacteria which permitted evaluation 
of the bacteriological conditions of only the main root canal.  Retamozo et al allowed the 
treated dentin cylinders to remain in brain-heart infusion (BHI) broth for 72 hours before 
determining if the bacteria had been eliminated, which allowed evaluation of the entire 
root canal complex.  In addition, Siquiera et al found that while the 1%, 2.5%, and 5.25% 
NaOCl reduced the bacterial percentage by 97.1%, 99.9%, and 99.8% respectively, 
bacteria were never thoroughly eliminated from the root canals as was accomplished in 
the Retamozo study.  Finally, Siquiera et al did not indicate times of exposure.  Similar 
studies using extracted teeth infected with E. faecalis have also failed to consistently 
eliminate all the E. faecalis contaminated within the dentinal tubules (82-85).    
Some reasons for the increase in difficulty to kill bacteria in teeth versus in a 
suspension test include the inhibitory effect of dentin on the disinfectant (86) and the 
challenge to penetrate into the dentinal tubules for direct contact with the bacteria.  While 
an in vitro test does not always reflect what is encountered clinically, it is beneficial for 
the initial comparison of test solutions as was performed in the present study.  The results 
in the present study indicate that STERIPLEX
TM
 HC performed similar to the 5.25% 
NaOCl in reducing the CFU to zero when used at 50%, 25% and 10% of the total 
suspension.  However, the 5.25% NaOCl was more effective than STERIPLEX™ HC in 
killing E. faecalis when it consisted of only 1% of the suspension after 1 minute of 
exposure. The same was true for the 0.1% suspension of disinfectant when exposed to E. 
faecalis for 3 and 5 minutes.            
  It is important to note that the concentration at which to use NaOCl has not been 
set forth.  Indeed, in the endodontic community there is debate as to which concentration 
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performs best with the least cytotoxicity.  The STERIPLEX™ HC solution, however, 
does have a set concentration which is the full concentration.  At that concentration the 
solution performed well.  In fact, even when diluted three times its directed use, it 
performed similarly to the NaOCl.  However, while NaOCl has been well studied, 
STERIPLEX™ HC just recently came to market and as such additional studies are 
required.  It would be interesting to study the possible cytotoxicity of STERIPLEX™ HC 
on periapical tissue given the company’s statement that when used as a disinfectant it is 
non-corrosive to the skin, does not exhibit oral or inhalational toxicities and stimulates 
only mild irritation when sprayed in the eyes (64).  It would also be interesting to study if 
STERIPLEX™ HC possesses the ability to remove the smear layer and compare it to 
EDTA.  PAA is the active ingredient in STERIPLEX™ HC and 0.5% PAA has been 
shown to be as effective as 17% EDTA in removing the smear layer after a 60 second 
exposure (71).  Other studies could be performed to elucidate if STERIPLEX™ HC 
possesses any properties of substantivity similar to CHX so as to replace CHX as an 
improved final rinse.  It is unknown if STERIPLEX™ HC remains active in the presence 
of dentin but it has been shown that dentin reduces the antimicrobial effectiveness of 
NaOCl and CHX (86).  It would be interesting to know if STERIPLEX™ HC deactivates 
LPS.  In addition, it would be interesting to determine if STERIPLEX™ HC reduces the 
flexural strength of dentin as does NaOCl (33). 
In conclusion, 5.25% NaOCl is more effective than STERIPLEX™ HC in 
reducing the CFU of E. faecalis in a suspension test at 1 minute for the 1% suspension (P 
< .0001) and at 3 and 5 minutes for the 0.1% suspension (P = 0.0098, P < .0001, 
respectively).  However, when 50%, 25%, or 10% of the solution consisted of 5.25% 
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NaOCl or STERIPLEX™ HC, the CFU was reduced to zero in one minute.  Further 
studies are thus warranted to determine if STERIPLEX™ HC posses other properties of 
an ideal endodontic irrigant when used at 50%, 25% or 10% of the total suspension.   
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Appendix 
 
Table 3: Raw Data Collection 
Conc% Trial Agent Dil ratio Rep Count CFU/ml 
0.01 1 Control 409600 Rep1 26 10649600 
0.01 1 Control 409600 Rep2 28 11468800 
0.01 1 Control 409600 Rep3 21 8601600 
0.01 1 Control 409600 Rep4 25 10240000 
0.01 1 Control 409600 Rep5 32 13107200 
0.01 1 Control 409600 Rep6 26 10649600 
0.01 1 NaOCl 1min 102400 Rep1 53 5427200 
0.01 1 NaOCl 1min 102400 Rep2 50 5120000 
0.01 1 NaOCl 1min 102400 Rep3 41 4198400 
0.01 1 NaOCl 1min 102400 Rep4 60 6144000 
0.01 1 NaOCl 1min 102400 Rep5 54 5529600 
0.01 1 NaOCl 1min 102400 Rep6 57 5836800 
0.01 1 NaOCl 3min 6400 Rep1 54 345600 
0.01 1 NaOCl 3min 6400 Rep2 44 281600 
0.01 1 NaOCl 3min 6400 Rep3 49 313600 
0.01 1 NaOCl 3min 6400 Rep4 50 320000 
0.01 1 NaOCl 3min 6400 Rep5 44 281600 
0.01 1 NaOCl 3min 6400 Rep6 43 275200 
0.01 1 NaOCl 5min 1600 Rep1 85 136000 
0.01 1 NaOCl 5min 1600 Rep2 67 107200 
0.01 1 NaOCl 5min 1600 Rep3 70 112000 
0.01 1 NaOCl 5min 1600 Rep4 75 120000 
0.01 1 NaOCl 5min 1600 Rep5 64 102400 
0.01 1 NaOCl 5min 1600 Rep6 71 113600 
0.01 1 Stpx 1min 1638400 Rep1 24 39321600 
0.01 1 Stpx 1min 1638400 Rep2 21 34406400 
0.01 1 Stpx 1min 1638400 Rep3 27 44236800 
0.01 1 Stpx 1min 1638400 Rep4 16 26214400 
0.01 1 Stpx 1min 1638400 Rep5 23 37683200 
0.01 1 Stpx 1min 1638400 Rep6 9 14745600 
0.01 1 Stpx 3min 1638400 Rep1 17 27852800 
0.01 1 Stpx 3min 1638400 Rep2 18 29491200 
0.01 1 Stpx 3min 1638400 Rep3 16 26214400 
0.01 1 Stpx 3min 1638400 Rep4 11 18022400 
0.01 1 Stpx 3min 1638400 Rep5 13 21299200 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
0.01 1 Stpx 3min 1638400 Rep6 15 24576000 
0.01 1 Stpx 5min 409600 Rep1 45 18432000 
0.01 1 Stpx 5min 409600 Rep2 39 15974400 
0.01 1 Stpx 5min 409600 Rep3 48 19660800 
0.01 1 Stpx 5min 409600 Rep4 43 17612800 
0.01 1 Stpx 5min 409600 Rep5 46 18841600 
0.01 1 Stpx 5min 409600 Rep6 44 18022400 
0.01 1 NaOCL+Neut 409600 Rep1 49 20070400 
0.01 1 NaOCL+Neut 409600 Rep2 57 23347200 
0.01 1 NaOCL+Neut 409600 Rep3 55 22528000 
0.01 1 Stpx+Neut 409600 Rep1 64 26214400 
0.01 1 Stpx+Neut 409600 Rep2 70 28672000 
0.01 1 Stpx+Neut 409600 Rep3 63 25804800 
0.01 1 neutral Stpx 409600 Rep1 57 23347200 
0.01 1 neutral Stpx 409600 Rep2 68 27852800 
0.01 1 neutral Stpx 409600 Rep3 72 29491200 
0.01 1 neut NaOCl 409600 Rep1 40 16384000 
0.01 1 neut NaOCl 409600 Rep2 64 26214400 
0.01 1 neut NaOCl 409600 Rep3 56 22937600 
0.01 2 Control 409600 Rep1 53 21708800 
0.01 2 Control 409600 Rep2 32 13107200 
0.01 2 Control 409600 Rep3 54 22118400 
0.01 2 Control 409600 Rep4 40 16384000 
0.01 2 Control 409600 Rep5 58 23756800 
0.01 2 Control 409600 Rep6 44 18022400 
0.01 2 NaOCl 1min 1638400 Rep1 15 24576000 
0.01 2 NaOCl 1min 1638400 Rep2 20 32768000 
0.01 2 NaOCl 1min 1638400 Rep3 16 26214400 
0.01 2 NaOCl 1min 1638400 Rep4 11 18022400 
0.01 2 NaOCl 1min 1638400 Rep5 20 32768000 
0.01 2 NaOCl 1min 1638400 Rep6 23 37683200 
0.01 2 NaOCl 3min 102400 Rep1 15 1536000 
0.01 2 NaOCl 3min 102400 Rep2 15 1536000 
0.01 2 NaOCl 3min 102400 Rep3 10 1024000 
0.01 2 NaOCl 3min 102400 Rep4 16 1638400 
0.01 2 NaOCl 3min 102400 Rep5 16 1638400 
0.01 2 NaOCl 3min 102400 Rep6 14 1433600 
0.01 2 NaOCl 5min 25600 Rep1 11 281600 
0.01 2 NaOCl 5min 25600 Rep2 18 460800 
0.01 2 NaOCl 5min 25600 Rep3 20 512000 
0.01 2 NaOCl 5min 25600 Rep4 18 460800 
0.01 2 NaOCl 5min 25600 Rep5 22 563200 
0.01 2 NaOCl 5min 25600 Rep6 15 384000 
0.01 2 Stpx 1min 409600 Rep1 32 13107200 
0.01 2 Stpx 1min 409600 Rep2 44 18022400 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
0.01 2 Stpx 1min 409600 Rep3 46 18841600 
0.01 2 Stpx 1min 409600 Rep4 28 11468800 
0.01 2 Stpx 1min 409600 Rep5 42 17203200 
0.01 2 Stpx 1min 409600 Rep6 41 16793600 
0.01 2 Stpx 3min 409600 Rep1 67 27443200 
0.01 2 Stpx 3min 409600 Rep2 59 24166400 
0.01 2 Stpx 3min 409600 Rep3 63 25804800 
0.01 2 Stpx 3min 409600 Rep4 65 26624000 
0.01 2 Stpx 3min 409600 Rep5 65 26624000 
0.01 2 Stpx 3min 409600 Rep6 66 27033600 
0.01 2 Stpx 5min 409600 Rep1 61 24985600 
0.01 2 Stpx 5min 409600 Rep2 72 29491200 
0.01 2 Stpx 5min 409600 Rep3 59 24166400 
0.01 2 Stpx 5min 409600 Rep4 62 25395200 
0.01 2 Stpx 5min 409600 Rep5 56 22937600 
0.01 2 Stpx 5min 409600 Rep6 59 24166400 
0.01 3 Control 409600 Rep1 53 21708800 
0.01 3 Control 409600 Rep2 32 13107200 
0.01 3 Control 409600 Rep3 54 22118400 
0.01 3 Control 409600 Rep4 40 16384000 
0.01 3 Control 409600 Rep5 58 23756800 
0.01 3 Control 409600 Rep6 44 18022400 
0.01 3 NaOCl 1min 409600 Rep1 37 15155200 
0.01 3 NaOCl 1min 409600 Rep2 34 13926400 
0.01 3 NaOCl 1min 409600 Rep3 27 11059200 
0.01 3 NaOCl 1min 409600 Rep4 36 14745600 
0.01 3 NaOCl 1min 409600 Rep5 36 14745600 
0.01 3 NaOCl 1min 409600 Rep6 34 13926400 
0.01 3 NaOCl 3min 409600 Rep1 22 9011200 
0.01 3 NaOCl 3min 409600 Rep2 23 9420800 
0.01 3 NaOCl 3min 409600 Rep3 29 11878400 
0.01 3 NaOCl 3min 409600 Rep4 28 11468800 
0.01 3 NaOCl 3min 409600 Rep5 26 10649600 
0.01 3 NaOCl 3min 409600 Rep6 24 9830400 
0.01 3 NaOCl 5min 102400 Rep1 85 8704000 
0.01 3 NaOCl 5min 102400 Rep2 89 9113600 
0.01 3 NaOCl 5min 102400 Rep3 96 9830400 
0.01 3 NaOCl 5min 102400 Rep4 93 9523200 
0.01 3 NaOCl 5min 102400 Rep5 84 8601600 
0.01 3 NaOCl 5min 102400 Rep6 82 8396800 
0.01 3 Stpx 1min 409600 Rep1 52 21299200 
0.01 3 Stpx 1min 409600 Rep2 60 24576000 
0.01 3 Stpx 1min 409600 Rep3 56 22937600 
0.01 3 Stpx 1min 409600 Rep4 77 31539200 
0.01 3 Stpx 1min 409600 Rep5 64 26214400 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
0.01 3 Stpx 1min 409600 Rep6 60 24576000 
0.01 3 Stpx 3min 409600 Rep1 66 27033600 
0.01 3 Stpx 3min 409600 Rep2 66 27033600 
0.01 3 Stpx 3min 409600 Rep3 63 25804800 
0.01 3 Stpx 3min 409600 Rep4 68 27852800 
0.01 3 Stpx 3min 409600 Rep5 55 22528000 
0.01 3 Stpx 3min 409600 Rep6 58 23756800 
0.01 3 Stpx 5min 409600 Rep1 61 24985600 
0.01 3 Stpx 5min 409600 Rep2 80 32768000 
0.01 3 Stpx 5min 409600 Rep3 73 29900800 
0.01 3 Stpx 5min 409600 Rep4 71 29081600 
0.01 3 Stpx 5min 409600 Rep5 58 23756800 
0.01 3 Stpx 5min 409600 Rep6 67 27443200 
0.1 0 Control 409600 Rep1 40 16384000 
0.1 0 Control 409600 Rep2 38 15564800 
0.1 0 Control 409600 Rep3 40 16384000 
0.1 0 Control 409600 Rep4 38 15564800 
0.1 0 Control 409600 Rep5 42 17203200 
0.1 0 Control 409600 Rep6 40 16384000 
0.1 1 NaOCl 1min 409600 Rep1 34 13926400 
0.1 1 NaOCl 1min 409600 Rep2 34 13926400 
0.1 1 NaOCl 1min 409600 Rep3 36 14745600 
0.1 1 NaOCl 1min 409600 Rep4 36 14745600 
0.1 1 NaOCl 1min 409600 Rep5 36 14745600 
0.1 1 NaOCl 1min 409600 Rep6 35 14336000 
0.1 1 NaOCl 3min 409600 Rep1 32 13107200 
0.1 1 NaOCl 3min 409600 Rep2 36 14745600 
0.1 1 NaOCl 3min 409600 Rep3 32 13107200 
0.1 1 NaOCl 3min 409600 Rep4 33 13516800 
0.1 1 NaOCl 3min 409600 Rep5 32 13107200 
0.1 1 NaOCl 3min 409600 Rep6 31 12697600 
0.1 1 NaOCl 5min 409600 Rep1 36 14745600 
0.1 1 NaOCl 5min 409600 Rep2 30 12288000 
0.1 1 NaOCl 5min 409600 Rep3 36 14745600 
0.1 1 NaOCl 5min 409600 Rep4 34 13926400 
0.1 1 NaOCl 5min 409600 Rep5 36 14745600 
0.1 1 NaOCl 5min 409600 Rep6 33 13516800 
0.1 2 NaOCl 1min 409600 Rep1 40 16384000 
0.1 2 NaOCl 1min 409600 Rep2 40 16384000 
0.1 2 NaOCl 1min 409600 Rep3 40 16384000 
0.1 2 NaOCl 1min 409600 Rep4 40 16384000 
0.1 2 NaOCl 1min 409600 Rep5 40 16384000 
0.1 2 NaOCl 1min 409600 Rep6 38 15564800 
0.1 2 NaOCl 3min 409600 Rep1 38 15564800 
0.1 2 NaOCl 3min 409600 Rep2 36 14745600 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
0.1 2 NaOCl 3min 409600 Rep3 36 14745600 
0.1 2 NaOCl 3min 409600 Rep4 30 12288000 
0.1 2 NaOCl 3min 409600 Rep5 33 13516800 
0.1 2 NaOCl 3min 409600 Rep6 34 13926400 
0.1 2 NaOCl 5min 409600 Rep1 24 9830400 
0.1 2 NaOCl 5min 409600 Rep2 24 9830400 
0.1 2 NaOCl 5min 409600 Rep3 26 10649600 
0.1 2 NaOCl 5min 409600 Rep4 34 13926400 
0.1 2 NaOCl 5min 409600 Rep5 27 11059200 
0.1 2 NaOCl 5min 409600 Rep6 24 9830400 
0.1 3 NaOCl 1min 409600 Rep1 40 16384000 
0.1 3 NaOCl 1min 409600 Rep2 39 15974400 
0.1 3 NaOCl 1min 409600 Rep3 38 15564800 
0.1 3 NaOCl 1min 409600 Rep4 39 15974400 
0.1 3 NaOCl 1min 409600 Rep5 40 16384000 
0.1 3 NaOCl 1min 409600 Rep6 38 15564800 
0.1 3 NaOCl 3min 409600 Rep1 40 16384000 
0.1 3 NaOCl 3min 409600 Rep2 40 16384000 
0.1 3 NaOCl 3min 409600 Rep3 38 15564800 
0.1 3 NaOCl 3min 409600 Rep4 38 15564800 
0.1 3 NaOCl 3min 409600 Rep5 39 15974400 
0.1 3 NaOCl 3min 409600 Rep6 39 15974400 
0.1 3 NaOCl 5min 409600 Rep1 35 14336000 
0.1 3 NaOCl 5min 409600 Rep2 30 12288000 
0.1 3 NaOCl 5min 409600 Rep3 35 14336000 
0.1 3 NaOCl 5min 409600 Rep4 36 14745600 
0.1 3 NaOCl 5min 409600 Rep5 36 14745600 
0.1 3 NaOCl 5min 409600 Rep6 36 14745600 
0.1 1 Stpx 1min 409600 Rep1 40 16384000 
0.1 1 Stpx 1min 409600 Rep2 40 16384000 
0.1 1 Stpx 1min 409600 Rep3 35 14336000 
0.1 1 Stpx 1min 409600 Rep4 41 16793600 
0.1 1 Stpx 1min 409600 Rep5 40 16384000 
0.1 1 Stpx 1min 409600 Rep6 40 16384000 
0.1 1 Stpx 3min 409600 Rep1 35 14336000 
0.1 1 Stpx 3min 409600 Rep2 36 14745600 
0.1 1 Stpx 3min 409600 Rep3 40 16384000 
0.1 1 Stpx 3min 409600 Rep4 40 16384000 
0.1 1 Stpx 3min 409600 Rep5 40 16384000 
0.1 1 Stpx 3min 409600 Rep6 35 14336000 
0.1 1 Stpx 5min 409600 Rep1 36 14745600 
0.1 1 Stpx 5min 409600 Rep2 37 15155200 
0.1 1 Stpx 5min 409600 Rep3 33 13516800 
0.1 1 Stpx 5min 409600 Rep4 39 15974400 
0.1 1 Stpx 5min 409600 Rep5 36 14745600 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
0.1 1 Stpx 5min 409600 Rep6 37 15155200 
0.1 2 Stpx 1min 409600 Rep1 39 15974400 
0.1 2 Stpx 1min 409600 Rep2 39 15974400 
0.1 2 Stpx 1min 409600 Rep3 38 15564800 
0.1 2 Stpx 1min 409600 Rep4 40 16384000 
0.1 2 Stpx 1min 409600 Rep5 38 15564800 
0.1 2 Stpx 1min 409600 Rep6 40 16384000 
0.1 2 Stpx 3min 409600 Rep1 38 15564800 
0.1 2 Stpx 3min 409600 Rep2 39 15974400 
0.1 2 Stpx 3min 409600 Rep3 38 15564800 
0.1 2 Stpx 3min 409600 Rep4 38 15564800 
0.1 2 Stpx 3min 409600 Rep5 40 16384000 
0.1 2 Stpx 3min 409600 Rep6 40 16384000 
0.1 2 Stpx 5min 409600 Rep1 40 16384000 
0.1 2 Stpx 5min 409600 Rep2 40 16384000 
0.1 2 Stpx 5min 409600 Rep3 40 16384000 
0.1 2 Stpx 5min 409600 Rep4 39 15974400 
0.1 2 Stpx 5min 409600 Rep5 36 14745600 
0.1 2 Stpx 5min 409600 Rep6 39 15974400 
0.1 3 Stpx 1min 409600 Rep1 39 15974400 
0.1 3 Stpx 1min 409600 Rep2 39 15974400 
0.1 3 Stpx 1min 409600 Rep3 40 16384000 
0.1 3 Stpx 1min 409600 Rep4 40 16384000 
0.1 3 Stpx 1min 409600 Rep5 40 16384000 
0.1 3 Stpx 1min 409600 Rep6 40 16384000 
0.1 3 Stpx 3min 409600 Rep1 40 16384000 
0.1 3 Stpx 3min 409600 Rep2 40 16384000 
0.1 3 Stpx 3min 409600 Rep3 39 15974400 
0.1 3 Stpx 3min 409600 Rep4 38 15564800 
0.1 3 Stpx 3min 409600 Rep5 40 16384000 
0.1 3 Stpx 3min 409600 Rep6 40 16384000 
0.1 3 Stpx 5min 409600 Rep1 40 16384000 
0.1 3 Stpx 5min 409600 Rep2 40 16384000 
0.1 3 Stpx 5min 409600 Rep3 40 16384000 
0.1 3 Stpx 5min 409600 Rep4 40 16384000 
0.1 3 Stpx 5min 409600 Rep5 39 15974400 
0.1 3 Stpx 5min 409600 Rep6 39 15974400 
1 0 Control 409600 Rep1 45 18432000 
1 0 Control 409600 Rep2 38 15564800 
1 0 Control 409600 Rep3 38 15564800 
1 0 Control 409600 Rep4 41 16793600 
1 0 Control 409600 Rep5 40 16384000 
1 0 Control 409600 Rep6 40 16384000 
1 1 NaOCl 1min 25600 Rep1 23 588800 
1 1 NaOCl 1min 25600 Rep2 20 512000 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
1 1 NaOCl 1min 25600 Rep3 20 512000 
1 1 NaOCl 1min 25600 Rep4 18 460800 
1 1 NaOCl 1min 25600 Rep5 23 588800 
1 1 NaOCl 1min 25600 Rep6 21 537600 
1 1 NaOCl 3min 1600 Rep1 28 44800 
1 1 NaOCl 3min 1600 Rep2 32 51200 
1 1 NaOCl 3min 1600 Rep3 31 49600 
1 1 NaOCl 3min 1600 Rep4 29 46400 
1 1 NaOCl 3min 1600 Rep5 34 54400 
1 1 NaOCl 3min 1600 Rep6 33 52800 
1 1 NaOCl 5min 100 Rep1 43 4300 
1 1 NaOCl 5min 100 Rep2 43 4300 
1 1 NaOCl 5min 100 Rep3 31 3100 
1 1 NaOCl 5min 100 Rep4 39 3900 
1 1 NaOCl 5min 100 Rep5 35 3500 
1 1 NaOCl 5min 100 Rep6 36 3600 
1 2 NaOCl 1min 25600 Rep1 38 972800 
1 2 NaOCl 1min 25600 Rep2 40 1024000 
1 2 NaOCl 1min 25600 Rep3 39 998400 
1 2 NaOCl 1min 25600 Rep4 38 972800 
1 2 NaOCl 1min 25600 Rep5 38 972800 
1 2 NaOCl 1min 25600 Rep6 40 1024000 
1 2 NaOCl 3min 1600 Rep1 34 54400 
1 2 NaOCl 3min 1600 Rep2 41 65600 
1 2 NaOCl 3min 1600 Rep3 39 62400 
1 2 NaOCl 3min 1600 Rep4 43 68800 
1 2 NaOCl 3min 1600 Rep5 40 64000 
1 2 NaOCl 3min 1600 Rep6 40 64000 
1 2 NaOCl 5min 100 Rep1 59 5900 
1 2 NaOCl 5min 100 Rep2 60 6000 
1 2 NaOCl 5min 100 Rep3 61 6100 
1 2 NaOCl 5min 100 Rep4 61 6100 
1 2 NaOCl 5min 100 Rep5 58 5800 
1 2 NaOCl 5min 100 Rep6 55 5500 
1 3 NaOCl 1min 25600 Rep1 37 947200 
1 3 NaOCl 1min 25600 Rep2 38 972800 
1 3 NaOCl 1min 25600 Rep3 39 998400 
1 3 NaOCl 1min 25600 Rep4 40 1024000 
1 3 NaOCl 1min 25600 Rep5 39 998400 
1 3 NaOCl 1min 25600 Rep6 38 972800 
1 3 NaOCl 3min 1600 Rep1 47 75200 
1 3 NaOCl 3min 1600 Rep2 39 62400 
1 3 NaOCl 3min 1600 Rep3 45 72000 
1 3 NaOCl 3min 1600 Rep4 46 73600 
1 3 NaOCl 3min 1600 Rep5 40 64000 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
1 3 NaOCl 3min 1600 Rep6 41 65600 
1 3 NaOCl 5min 400 Rep1 30 12000 
1 3 NaOCl 5min 400 Rep2 39 15600 
1 3 NaOCl 5min 400 Rep3 34 13600 
1 3 NaOCl 5min 400 Rep4 30 12000 
1 3 NaOCl 5min 400 Rep5 30 12000 
1 3 NaOCl 5min 400 Rep6 31 12400 
1 1 Stpx 1min 409600 Rep1 46 18841600 
1 1 Stpx 1min 409600 Rep2 34 13926400 
1 1 Stpx 1min 409600 Rep3 43 17612800 
1 1 Stpx 1min 409600 Rep4 45 18432000 
1 1 Stpx 1min 409600 Rep5 36 14745600 
1 1 Stpx 1min 409600 Rep6 39 15974400 
1 1 Stpx 3min 409600 Rep1 35 14336000 
1 1 Stpx 3min 409600 Rep2 43 17612800 
1 1 Stpx 3min 409600 Rep3 43 17612800 
1 1 Stpx 3min 409600 Rep4 36 14745600 
1 1 Stpx 3min 409600 Rep5 39 15974400 
1 1 Stpx 3min 409600 Rep6 41 16793600 
1 1 Stpx 5min 409600 Rep1 40 16384000 
1 1 Stpx 5min 409600 Rep2 37 15155200 
1 1 Stpx 5min 409600 Rep3 41 16793600 
1 1 Stpx 5min 409600 Rep4 43 17612800 
1 1 Stpx 5min 409600 Rep5 42 17203200 
1 1 Stpx 5min 409600 Rep6 39 15974400 
1 2 Stpx 1min 409600 Rep1 42 17203200 
1 2 Stpx 1min 409600 Rep2 40 16384000 
1 2 Stpx 1min 409600 Rep3 40 16384000 
1 2 Stpx 1min 409600 Rep4 39 15974400 
1 2 Stpx 1min 409600 Rep5 38 15564800 
1 2 Stpx 1min 409600 Rep6 43 17612800 
1 2 Stpx 3min 409600 Rep1 42 17203200 
1 2 Stpx 3min 409600 Rep2 42 17203200 
1 2 Stpx 3min 409600 Rep3 41 16793600 
1 2 Stpx 3min 409600 Rep4 40 16384000 
1 2 Stpx 3min 409600 Rep5 38 15564800 
1 2 Stpx 3min 409600 Rep6 40 16384000 
1 2 Stpx 5min 409600 Rep1 35 14336000 
1 2 Stpx 5min 409600 Rep2 43 17612800 
1 2 Stpx 5min 409600 Rep3 45 18432000 
1 2 Stpx 5min 409600 Rep4 36 14745600 
1 2 Stpx 5min 409600 Rep5 44 18022400 
1 2 Stpx 5min 409600 Rep6 39 15974400 
1 3 Stpx 1min 409600 Rep1 39 15974400 
1 3 Stpx 1min 409600 Rep2 34 13926400 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
1 3 Stpx 1min 409600 Rep3 40 16384000 
1 3 Stpx 1min 409600 Rep4 40 16384000 
1 3 Stpx 1min 409600 Rep5 35 14336000 
1 3 Stpx 1min 409600 Rep6 35 14336000 
1 3 Stpx 3min 409600 Rep1 42 17203200 
1 3 Stpx 3min 409600 Rep2 35 14336000 
1 3 Stpx 3min 409600 Rep3 37 15155200 
1 3 Stpx 3min 409600 Rep4 34 13926400 
1 3 Stpx 3min 409600 Rep5 40 16384000 
1 3 Stpx 3min 409600 Rep6 36 14745600 
1 3 Stpx 5min 409600 Rep1 40 16384000 
1 3 Stpx 5min 409600 Rep2 40 16384000 
1 3 Stpx 5min 409600 Rep3 40 16384000 
1 3 Stpx 5min 409600 Rep4 40 16384000 
1 3 Stpx 5min 409600 Rep5 41 16793600 
1 3 Stpx 5min 409600 Rep6 40 16384000 
10 0 Control 409600 Rep1 43 17612800 
10 0 Control 409600 Rep2 40 16384000 
10 0 Control 409600 Rep3 36 14745600 
10 0 Control 409600 Rep4 36 14745600 
10 0 Control 409600 Rep5 39 15974400 
10 0 Control 409600 Rep6 44 18022400 
10 1 NaOCl 1min 100 Rep1 0 < 50 
10 1 NaOCl 1min 100 Rep2 0 < 50 
10 1 NaOCl 1min 100 Rep3 0 < 50 
10 1 NaOCl 1min 100 Rep4 0 <50 
10 1 NaOCl 1min 100 Rep5 0 < 50 
10 1 NaOCl 1min 100 Rep6 0 < 50 
10 1 NaOCl 3min 100 Rep1 0 < 50 
10 1 NaOCl 3min 100 Rep2 0 <50 
10 1 NaOCl 3min 100 Rep3 0 < 50 
10 1 NaOCl 3min 100 Rep4 0 < 50 
10 1 NaOCl 3min 100 Rep5 0 < 50 
10 1 NaOCl 3min 100 Rep6 0 < 50 
10 1 NaOCl 5min 100 Rep1 0 <50 
10 1 NaOCl 5min 100 Rep2 0 < 50 
10 1 NaOCl 5min 100 Rep3 0 < 50 
10 1 NaOCl 5min 100 Rep4 0 < 50 
10 1 NaOCl 5min 100 Rep5 0 <50 
10 1 NaOCl 5min 100 Rep6 0 < 50 
10 2 NaOCl 1min 100 Rep1 0 < 50 
10 2 NaOCl 1min 100 Rep2 0 < 50 
10 2 NaOCl 1min 100 Rep3 0 < 50 
10 2 NaOCl 1min 100 Rep4 0 <50 
10 2 NaOCl 1min 100 Rep5 0 < 50 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
10 2 NaOCl 1min 100 Rep6 0 < 50 
10 2 NaOCl 3min 100 Rep1 0 < 50 
10 2 NaOCl 3min 100 Rep2 0 <50 
10 2 NaOCl 3min 100 Rep3 0 < 50 
10 2 NaOCl 3min 100 Rep4 0 < 50 
10 2 NaOCl 3min 100 Rep5 0 < 50 
10 2 NaOCl 3min 100 Rep6 0 < 50 
10 2 NaOCl 5min 100 Rep1 0 < 50 
10 2 NaOCl 5min 100 Rep2 0 < 50 
10 2 NaOCl 5min 100 Rep3 0 <50 
10 2 NaOCl 5min 100 Rep4 0 < 50 
10 2 NaOCl 5min 100 Rep5 0 < 50 
10 2 NaOCl 5min 100 Rep6 0 < 50 
10 3 NaOCl 1min 100 Rep1 0 <50 
10 3 NaOCl 1min 100 Rep2 0 < 50 
10 3 NaOCl 1min 100 Rep3 0 < 50 
10 3 NaOCl 1min 100 Rep4 0 < 50 
10 3 NaOCl 1min 100 Rep5 0 < 50 
10 3 NaOCl 1min 100 Rep6 0 <50 
10 3 NaOCl 3min 100 Rep1 0 < 50 
10 3 NaOCl 3min 100 Rep2 0 < 50 
10 3 NaOCl 3min 100 Rep3 0 < 50 
10 3 NaOCl 3min 100 Rep4 0 <50 
10 3 NaOCl 3min 100 Rep5 0 < 50 
10 3 NaOCl 3min 100 Rep6 0 < 50 
10 3 NaOCl 5min 100 Rep1 0 < 50 
10 3 NaOCl 5min 100 Rep2 0 < 50 
10 3 NaOCl 5min 100 Rep3 0 <50 
10 3 NaOCl 5min 100 Rep4 0 < 50 
10 3 NaOCl 5min 100 Rep5 0 < 50 
10 3 NaOCl 5min 100 Rep6 0 < 50 
10 1 Stpx 1min 100 Rep1 0 <50 
10 1 Stpx 1min 100 Rep2 0 < 50 
10 1 Stpx 1min 100 Rep3 0 < 50 
10 1 Stpx 1min 100 Rep4 0 < 50 
10 1 Stpx 1min 100 Rep5 0 < 50 
10 1 Stpx 1min 100 Rep6 0 < 50 
10 1 Stpx 3min 100 Rep1 0 <50 
10 1 Stpx 3min 100 Rep2 0 < 50 
10 1 Stpx 3min 100 Rep3 0 < 50 
10 1 Stpx 3min 100 Rep4 0 < 50 
10 1 Stpx 3min 100 Rep5 0 <50 
10 1 Stpx 3min 100 Rep6 0 < 50 
10 1 Stpx 5min 100 Rep1 0 < 50 
10 1 Stpx 5min 100 Rep2 0 < 50 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
10 1 Stpx 5min 100 Rep3 0 < 50 
10 1 Stpx 5min 100 Rep4 0 <50 
10 1 Stpx 5min 100 Rep5 0 < 50 
10 1 Stpx 5min 100 Rep6 0 < 50 
10 2 Stpx 1min 100 Rep1 0 < 50 
10 2 Stpx 1min 100 Rep2 0 <50 
10 2 Stpx 1min 100 Rep3 0 < 50 
10 2 Stpx 1min 100 Rep4 0 < 50 
10 2 Stpx 1min 100 Rep5 0 < 50 
10 2 Stpx 1min 100 Rep6 0 <50 
10 2 Stpx 3min 100 Rep1 0 < 50 
10 2 Stpx 3min 100 Rep2 0 < 50 
10 2 Stpx 3min 100 Rep3 0 < 50 
10 2 Stpx 3min 100 Rep4 0 <50 
10 2 Stpx 3min 100 Rep5 0 < 50 
10 2 Stpx 3min 100 Rep6 0 < 50 
10 2 Stpx 5min 100 Rep1 0 < 50 
10 2 Stpx 5min 100 Rep2 0 < 50 
10 2 Stpx 5min 100 Rep3 0 <50 
10 2 Stpx 5min 100 Rep4 0 < 50 
10 2 Stpx 5min 100 Rep5 0 < 50 
10 2 Stpx 5min 100 Rep6 0 < 50 
10 3 Stpx 1min 100 Rep1 0 <50 
10 3 Stpx 1min 100 Rep2 0 < 50 
10 3 Stpx 1min 100 Rep3 0 < 50 
10 3 Stpx 1min 100 Rep4 0 < 50 
10 3 Stpx 1min 100 Rep5 0 < 50 
10 3 Stpx 1min 100 Rep6 0 <50 
10 3 Stpx 3min 100 Rep1 0 < 50 
10 3 Stpx 3min 100 Rep2 0 < 50 
10 3 Stpx 3min 100 Rep3 0 < 50 
10 3 Stpx 3min 100 Rep4 0 <50 
10 3 Stpx 3min 100 Rep5 0 < 50 
10 3 Stpx 3min 100 Rep6 0 < 50 
10 3 Stpx 5min 100 Rep1 0 < 50 
10 3 Stpx 5min 100 Rep2 0 < 50 
10 3 Stpx 5min 100 Rep3 0 <50 
10 3 Stpx 5min 100 Rep4 0 < 50 
10 3 Stpx 5min 100 Rep5 0 < 50 
10 3 Stpx 5min 100 Rep6 0 < 50 
25 0 Control 409600 Rep1 36 14745600 
25 0 Control 409600 Rep2 46 18841600 
25 0 Control 409600 Rep3 46 18841600 
25 0 Control 409600 Rep4 42 17203200 
25 0 Control 409600 Rep5 46 18841600 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
25 0 Control 409600 Rep6 42 17203200 
25 1 NaOCl 1min 100 Rep1 0 < 50 
25 1 NaOCl 1min 100 Rep2 0 < 50 
25 1 NaOCl 1min 100 Rep3 0 < 50 
25 1 NaOCl 1min 100 Rep4 0 <50 
25 1 NaOCl 1min 100 Rep5 0 < 50 
25 1 NaOCl 1min 100 Rep6 0 < 50 
25 1 NaOCl 3min 100 Rep1 0 < 50 
25 1 NaOCl 3min 100 Rep2 0 <50 
25 1 NaOCl 3min 100 Rep3 0 < 50 
25 1 NaOCl 3min 100 Rep4 0 < 50 
25 1 NaOCl 3min 100 Rep5 0 < 50 
25 1 NaOCl 3min 100 Rep6 0 < 50 
25 1 NaOCl 5min 100 Rep1 0 <50 
25 1 NaOCl 5min 100 Rep2 0 < 50 
25 1 NaOCl 5min 100 Rep3 0 < 50 
25 1 NaOCl 5min 100 Rep4 0 < 50 
25 1 NaOCl 5min 100 Rep5 0 <50 
25 1 NaOCl 5min 100 Rep6 0 < 50 
25 2 NaOCl 1min 100 Rep1 0 < 50 
25 2 NaOCl 1min 100 Rep2 0 < 50 
25 2 NaOCl 1min 100 Rep3 0 < 50 
25 2 NaOCl 1min 100 Rep4 0 <50 
25 2 NaOCl 1min 100 Rep5 0 < 50 
25 2 NaOCl 1min 100 Rep6 0 < 50 
25 2 NaOCl 3min 100 Rep1 0 < 50 
25 2 NaOCl 3min 100 Rep2 0 <50 
25 2 NaOCl 3min 100 Rep3 0 < 50 
25 2 NaOCl 3min 100 Rep4 0 < 50 
25 2 NaOCl 3min 100 Rep5 0 < 50 
25 2 NaOCl 3min 100 Rep6 0 < 50 
25 2 NaOCl 5min 100 Rep1 0 <50 
25 2 NaOCl 5min 100 Rep2 0 < 50 
25 2 NaOCl 5min 100 Rep3 0 < 50 
25 2 NaOCl 5min 100 Rep4 0 < 50 
25 2 NaOCl 5min 100 Rep5 0 <50 
25 2 NaOCl 5min 100 Rep6 0 < 50 
25 3 NaOCl 1min 100 Rep1 0 < 50 
25 3 NaOCl 1min 100 Rep2 0 < 50 
25 3 NaOCl 1min 100 Rep3 0 < 50 
25 3 NaOCl 1min 100 Rep4 0 <50 
25 3 NaOCl 1min 100 Rep5 0 < 50 
25 3 NaOCl 1min 100 Rep6 0 < 50 
25 3 NaOCl 3min 100 Rep1 0 < 50 
25 3 NaOCl 3min 100 Rep2 0 <50 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
25 3 NaOCl 3min 100 Rep3 0 < 50 
25 3 NaOCl 3min 100 Rep4 0 < 50 
25 3 NaOCl 3min 100 Rep5 0 < 50 
25 3 NaOCl 3min 100 Rep6 0 < 50 
25 3 NaOCl 5min 100 Rep1 0 <50 
25 3 NaOCl 5min 100 Rep2 0 < 50 
25 3 NaOCl 5min 100 Rep3 0 < 50 
25 3 NaOCl 5min 100 Rep4 0 < 50 
25 3 NaOCl 5min 100 Rep5 0 <50 
25 3 NaOCl 5min 100 Rep6 0 < 50 
25 1 Stpx 1min 100 Rep1 0 < 50 
25 1 Stpx 1min 100 Rep2 0 < 50 
25 1 Stpx 1min 100 Rep3 0 < 50 
25 1 Stpx 1min 100 Rep4 0 <50 
25 1 Stpx 1min 100 Rep5 0 < 50 
25 1 Stpx 1min 100 Rep6 0 < 50 
25 1 Stpx 3min 100 Rep1 0 < 50 
25 1 Stpx 3min 100 Rep2 0 <50 
25 1 Stpx 3min 100 Rep3 0 < 50 
25 1 Stpx 3min 100 Rep4 0 < 50 
25 1 Stpx 3min 100 Rep5 0 < 50 
25 1 Stpx 3min 100 Rep6 0 < 50 
25 1 Stpx 5min 100 Rep1 0 <50 
25 1 Stpx 5min 100 Rep2 0 < 50 
25 1 Stpx 5min 100 Rep3 0 < 50 
25 1 Stpx 5min 100 Rep4 0 < 50 
25 1 Stpx 5min 100 Rep5 0 <50 
25 1 Stpx 5min 100 Rep6 0 < 50 
25 2 Stpx 1min 100 Rep1 0 < 50 
25 2 Stpx 1min 100 Rep2 0 < 50 
25 2 Stpx 1min 100 Rep3 0 < 50 
25 2 Stpx 1min 100 Rep4 0 <50 
25 2 Stpx 1min 100 Rep5 0 < 50 
25 2 Stpx 1min 100 Rep6 0 < 50 
25 2 Stpx 3min 100 Rep1 0 < 50 
25 2 Stpx 3min 100 Rep2 0 <50 
25 2 Stpx 3min 100 Rep3 0 < 50 
25 2 Stpx 3min 100 Rep4 0 < 50 
25 2 Stpx 3min 100 Rep5 0 < 50 
25 2 Stpx 3min 100 Rep6 0 < 50 
25 2 Stpx 5min 100 Rep1 0 <50 
25 2 Stpx 5min 100 Rep2 0 < 50 
25 2 Stpx 5min 100 Rep3 0 < 50 
25 2 Stpx 5min 100 Rep4 0 < 50 
25 2 Stpx 5min 100 Rep5 0 <50 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
25 2 Stpx 5min 100 Rep6 0 < 50 
25 3 Stpx 1min 100 Rep1 0 < 50 
25 3 Stpx 1min 100 Rep2 0 < 50 
25 3 Stpx 1min 100 Rep3 0 < 50 
25 3 Stpx 1min 100 Rep4 0 <50 
25 3 Stpx 1min 100 Rep5 0 < 50 
25 3 Stpx 1min 100 Rep6 0 < 50 
25 3 Stpx 3min 100 Rep1 0 < 50 
25 3 Stpx 3min 100 Rep2 0 <50 
25 3 Stpx 3min 100 Rep3 0 < 50 
25 3 Stpx 3min 100 Rep4 0 < 50 
25 3 Stpx 3min 100 Rep5 0 < 50 
25 3 Stpx 3min 100 Rep6 0 < 50 
25 3 Stpx 5min 100 Rep1 0 <50 
25 3 Stpx 5min 100 Rep2 0 < 50 
25 3 Stpx 5min 100 Rep3 0 < 50 
25 3 Stpx 5min 100 Rep4 0 < 50 
25 3 Stpx 5min 100 Rep5 0 <50 
25 3 Stpx 5min 100 Rep6 0 < 50 
50 0 Control 409600 Rep1 40 16384000 
50 0 Control 409600 Rep2 36 14745600 
50 0 Control 409600 Rep3 38 15564800 
50 0 Control 409600 Rep4 44 18022400 
50 0 Control 409600 Rep5 38 15564800 
50 0 Control 409600 Rep6 42 17203200 
50 1 NaOCl 1min 100 Rep1 0 < 50 
50 1 NaOCl 1min 100 Rep2 0 < 50 
50 1 NaOCl 1min 100 Rep3 0 < 50 
50 1 NaOCl 1min 100 Rep4 0 <50 
50 1 NaOCl 1min 100 Rep5 0 < 50 
50 1 NaOCl 1min 100 Rep6 0 < 50 
50 1 NaOCl 3min 100 Rep1 0 < 50 
50 1 NaOCl 3min 100 Rep2 0 <50 
50 1 NaOCl 3min 100 Rep3 0 < 50 
50 1 NaOCl 3min 100 Rep4 0 < 50 
50 1 NaOCl 3min 100 Rep5 0 < 50 
50 1 NaOCl 3min 100 Rep6 0 < 50 
50 1 NaOCl 5min 100 Rep1 0 <50 
50 1 NaOCl 5min 100 Rep2 0 < 50 
50 1 NaOCl 5min 100 Rep3 0 < 50 
50 1 NaOCl 5min 100 Rep4 0 < 50 
50 1 NaOCl 5min 100 Rep5 0 <50 
50 1 NaOCl 5min 100 Rep6 0 < 50 
50 2 NaOCl 1min 100 Rep1 0 < 50 
50 2 NaOCl 1min 100 Rep2 0 < 50 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
50 2 NaOCl 1min 100 Rep3 0 < 50 
50 2 NaOCl 1min 100 Rep4 0 <50 
50 2 NaOCl 1min 100 Rep5 0 < 50 
50 2 NaOCl 1min 100 Rep6 0 < 50 
50 2 NaOCl 3min 100 Rep1 0 < 50 
50 2 NaOCl 3min 100 Rep2 0 <50 
50 2 NaOCl 3min 100 Rep3 0 < 50 
50 2 NaOCl 3min 100 Rep4 0 < 50 
50 2 NaOCl 3min 100 Rep5 0 < 50 
50 2 NaOCl 3min 100 Rep6 0 < 50 
50 2 NaOCl 5min 100 Rep1 0 <50 
50 2 NaOCl 5min 100 Rep2 0 < 50 
50 2 NaOCl 5min 100 Rep3 0 < 50 
50 2 NaOCl 5min 100 Rep4 0 < 50 
50 2 NaOCl 5min 100 Rep5 0 <50 
50 2 NaOCl 5min 100 Rep6 0 < 50 
50 3 NaOCl 1min 100 Rep1 0 < 50 
50 3 NaOCl 1min 100 Rep2 0 < 50 
50 3 NaOCl 1min 100 Rep3 0 < 50 
50 3 NaOCl 1min 100 Rep4 0 <50 
50 3 NaOCl 1min 100 Rep5 0 < 50 
50 3 NaOCl 1min 100 Rep6 0 < 50 
50 3 NaOCl 3min 100 Rep1 0 < 50 
50 3 NaOCl 3min 100 Rep2 0 <50 
50 3 NaOCl 3min 100 Rep3 0 < 50 
50 3 NaOCl 3min 100 Rep4 0 < 50 
50 3 NaOCl 3min 100 Rep5 0 < 50 
50 3 NaOCl 3min 100 Rep6 0 < 50 
50 3 NaOCl 5min 100 Rep1 0 <50 
50 3 NaOCl 5min 100 Rep2 0 < 50 
50 3 NaOCl 5min 100 Rep3 0 < 50 
50 3 NaOCl 5min 100 Rep4 0 < 50 
50 3 NaOCl 5min 100 Rep5 0 <50 
50 3 NaOCl 5min 100 Rep6 0 < 50 
50 1 Stpx 1min 100 Rep1 0 < 50 
50 1 Stpx 1min 100 Rep2 0 < 50 
50 1 Stpx 1min 100 Rep3 0 < 50 
50 1 Stpx 1min 100 Rep4 0 <50 
50 1 Stpx 1min 100 Rep5 0 < 50 
50 1 Stpx 1min 100 Rep6 0 < 50 
50 1 Stpx 3min 100 Rep1 0 < 50 
50 1 Stpx 3min 100 Rep2 0 <50 
50 1 Stpx 3min 100 Rep3 0 < 50 
50 1 Stpx 3min 100 Rep4 0 < 50 
50 1 Stpx 3min 100 Rep5 0 < 50 
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Conc% Trial Agent Dil ratio Rep Count CFU/ml 
50 1 Stpx 3min 100 Rep6 0 < 50 
50 1 Stpx 5min 100 Rep1 0 <50 
50 1 Stpx 5min 100 Rep2 0 < 50 
50 1 Stpx 5min 100 Rep3 0 < 50 
50 1 Stpx 5min 100 Rep4 0 < 50 
50 1 Stpx 5min 100 Rep5 0 <50 
50 1 Stpx 5min 100 Rep6 0 < 50 
50 2 Stpx 1min 100 Rep1 0 < 50 
50 2 Stpx 1min 100 Rep2 0 < 50 
50 2 Stpx 1min 100 Rep3 0 < 50 
50 2 Stpx 1min 100 Rep4 0 <50 
50 2 Stpx 1min 100 Rep5 0 < 50 
50 2 Stpx 1min 100 Rep6 0 < 50 
50 2 Stpx 3min 100 Rep1 0 < 50 
50 2 Stpx 3min 100 Rep2 0 <50 
50 2 Stpx 3min 100 Rep3 0 < 50 
50 2 Stpx 3min 100 Rep4 0 < 50 
50 2 Stpx 3min 100 Rep5 0 < 50 
50 2 Stpx 3min 100 Rep6 0 < 50 
50 2 Stpx 5min 100 Rep1 0 <50 
50 2 Stpx 5min 100 Rep2 0 < 50 
50 2 Stpx 5min 100 Rep3 0 < 50 
50 2 Stpx 5min 100 Rep4 0 < 50 
50 2 Stpx 5min 100 Rep5 0 <50 
50 2 Stpx 5min 100 Rep6 0 < 50 
50 3 Stpx 1min 100 Rep1 0 < 50 
50 3 Stpx 1min 100 Rep2 0 < 50 
50 3 Stpx 1min 100 Rep3 0 < 50 
50 3 Stpx 1min 100 Rep4 0 <50 
50 3 Stpx 1min 100 Rep5 0 < 50 
50 3 Stpx 1min 100 Rep6 0 < 50 
50 3 Stpx 3min 100 Rep1 0 < 50 
50 3 Stpx 3min 100 Rep2 0 <50 
50 3 Stpx 3min 100 Rep3 0 < 50 
50 3 Stpx 3min 100 Rep4 0 < 50 
50 3 Stpx 3min 100 Rep5 0 < 50 
50 3 Stpx 3min 100 Rep6 0 < 50 
50 3 Stpx 5min 100 Rep1 0 <50 
50 3 Stpx 5min 100 Rep2 0 < 50 
50 3 Stpx 5min 100 Rep3 0 < 50 
50 3 Stpx 5min 100 Rep4 0 < 50 
50 3 Stpx 5min 100 Rep5 0 <50 
50 3 Stpx 5min 100 Rep6 0 < 50 
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Figure 6: Picture of E. faecalis/Disinfectant Test Tubes  
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Figure 7: Picture of Dilution Series  
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Figure 8: Picture of CFU’s on Agar Plates (Drop Plating)   
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